Accentia Biopharmaceuticals Inc. (ABPI) Stock Quote

Detailed Quote for Accentia Biopharmaceuticals Inc. (ABPI)

close 52 Week Information

52 Week High

February 14, 2011

Close: 0.75

52 Week Low

January 5, 2012

Close: 0.26

Today

Last Price
0.51

Change $

Change %

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
0.53

High
0.53

Low
0.50

Prev Close
0.51

Last Trade
2/10/12

Volume
14.2 k

52 Wk Hi
0.75

52 Wk Low
0.26

Market Cap
38.37 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
75,238,376

EPS (TTM)
-1.34

PE Ratio
N/A

close Exchange Information Listed On OTCQB - U.S. Registered (OTCQB) Exchange
OTCQB

News and Media for Accentia Biopharmaceuticals Inc. (ABPI)

Sector News | Topic News

News for ABPI

Mon, Feb 06, 2012

9:20 AM

BiovaxID® Personalized Lymphoma Vaccine is Featured in Article Published in HemOnc Today - Business Wire

Wed, Feb 01, 2012

9:45 AM

OneMedPlace Initiates Research Coverage on Biovest and BiovaxID® Personalized Lymphoma Vaccine - Business Wire

Thu, Jan 19, 2012

9:15 AM

Biovest Prepares for EU Regulatory Meetings; SME Status Granted Providing European Regulatory Benefits for BiovaxID Personalized Lymphoma Vaccine - Business Wire

Thu, Jan 12, 2012

10:47 AM

Biovest Collaborates with Max Planck Institute to Advance its Hollow Fiber Bioreactors for the Manufacture of Viral Vaccines - Business Wire

Tue, Jan 10, 2012

9:25 AM

Article Published on Fox News Website Predicts the Advance of Cancer Vaccines in 2012 including BiovaxID® Lymphoma Vaccine - Business Wire

Tue, Dec 20, 2011

11:03 AM

BiovaxID® Lymphoma Vaccine is Featured in Article Published in Yale Journal of Biology and Medicine - Business Wire

7:20 AM

Accentia Biopharmaceuticals Completes Sale of Analytica Subsidiary - Business Wire

Tue, Dec 13, 2011

11:41 AM

BiovaxID® Lymphoma Vaccine-Induced T-Cell Immune Responses Complement Rituximab Induction Chemotherapy and Significantly Correlate with Overall Survival in Mantle Cell Lymphoma - Business Wire

Tue, Nov 22, 2011

7:15 AM

Biovest Defines Role of BiovaxID® Personalized Cancer Vaccine in Journal of Clinical Oncology - Business Wire

More News for ABPI >>

Tags for Accentia Biopharmaceuticals Inc.

Research stocks or mutual funds related to Accentia Biopharmaceuticals Inc. by keywords or tags. Find companies that have a similar focus to ABPI. The keywords below have been associated to ABPI by either user submission or electronic means.

clinical trials database biotech research clinical trial enrollment clinical research trial clinical research software clinical development pharmaceuticals clinical trials generic pharmaceutical clinical research consulting medical product development outsourcing clinical trials Biological Products clinical trials uk clinical research enrollment clinical trials pharmaceutical cro pharmaceutical sales european clinical trials chronic sinusitis medical research pharmaceutical development pharmaceutical reports And Druggists' Sundries (5122) clinical research studies biotech patient recruitment clinical trials biotechnology research worldwide clinical trials physician clinical trials Drugs pharmaceutical auctions pharma clinical trials clinical trials recruitment cancer clinical trial clinical trials conference pharmaceutical trials clinical clinical trial conference medical device clinical trial clinical drug trials pharmaceutical industry life science products clinical research trials medical device medical contract manufacturing clinical trials europe medical clinical trials international clinical trials medical trials cancers